Blood-Based Untargeted Metabolomics in Relapsing-Remitting Multiple Sclerosis Revealed the Testable Therapeutic Target

Presenter Information

Shailendra Giri, Henry Ford HealthFollow
Suresh Palaniyandi, Henry Ford HealthFollow

Start Date

19-5-2023 11:00 AM

Recommended Citation

Giri, Shailendra and Palaniyandi, Suresh, "Blood-Based Untargeted Metabolomics in Relapsing-Remitting Multiple Sclerosis Revealed the Testable Therapeutic Target" (2023). Henry Ford Medical Group Research Symposium. 12.
https://scholarlycommons.henryford.com/hfmgrs/2023/Program/12